Dr Gisela Robles Aguilar
Gisela Robles Aguilar
Global Burden of Disease Researcher
Gisela joined GRAM as a Global Burden of Disease Researcher in 2018, and she supports efforts to estimate the burden of antimicrobial resistance worldwide and inform public health decision-making at the local and international levels. In the last three years, Gisela has collaborated with the Lancet Noncommunicable Diseases and Injuries (NCDIs) Poverty Commission by profiling risk factors to NCDIs across the poorest populations in the World, applying methodologies utilised by the Institute of Health Metrics (IHME) in its ongoing Global Burden of Disease (GBD) study. Gisela has also served as a Data Analyst at Oxford’s Clinical Trials Service Unit and Research Officer at the Oxford Poverty and Human Development Initiative (OPHI).
Gisela received her DPhil in Social Policy from Oxford in 2014, with a focus on modelling participation in conditional cash transfers.
Aguilar GR. et al, (2023), The Lancet Regional Health - Americas, 100561 - 100561
Ikuta KS. et al, (2022), The Lancet
European Antimicrobial Resistance Collaborators None., (2022), Lancet Public Health, 7, e897 - e913
Antimicrobial Resistance Collaborators None., (2022), Lancet, 399, 629 - 655
Coates MM. et al, (2021), PLoS One, 16